Violet Zahedi is a physician-turned-serial-founder with deep expertise in oncology and hematology. As CEO of Synamics Therapeutics, she leads the development of an AI platform to combat cancer treatment resistance. A board member of the Beverly Hills Chamber of Commerce, she focuses on bridging technology and community business. Colleagues describe her as innovative, passionate, and determined.
Fueled by her clinical experiences, Violet is driven by a mission to solve systemic problems that prevent innovations from reaching patients. This passion extends beyond healthcare to building ecosystems, like her venture Xivius, designed to support founders and scale transformative ideas globally. She is a member of the Los Angeles Venture Association.
Unique fact: Her journey into the pharmaceutical industry began with her curiosity about what physicians could achieve outside the clinic, leading to roles at Novo Nordisk.
Read the full overview →They generally do not appreciate an overfriendly approach and prefer to stay to-the-point. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters. They are more likely than others to negotiate on pricing and terms.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.